about
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differ...
Read More
53.52
-0.06
(-0.11%)
144.0K
XNAS Volume
XNAS 03 Sep, 2025 1:40 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..